Literature DB >> 12171552

DNA-binding antitumor agents: from pyrimido[5,6,1-de]acridines to other intriguing classes of acridine derivatives.

Ippolito Antonini1.   

Abstract

In the field of antitumor DNA-binding agents, the class of acridine derivatives play an important role either as number of compounds or as importance of their anticancer properties. We have synthesized a number of acridine derivatives as potential antitumor drugs, in which the chromophore is fully or partially constituted by acridine or by 9-acridone ring systems: from the pyrimido[5,6,1-de]acridines, to the pyrimido[4,5,6-kl]acridines, the bis(amine-functionalized) 9-acridone-4-carboxamides, the bis(amine-functionalized) acridine-4-carboxamides, and the pyrazolo[3,4,5-kl]acridine-5-carboxamides. In the present revue we will describe the rational design, the synthesis, and the salient biological characteristics of these classes of acridine derivatives.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12171552     DOI: 10.2174/0929867023369268

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

Review 1.  A Review on Fused Pyrimidine Systems as EGFR Inhibitors and Their Structure-Activity Relationship.

Authors:  Tanuja T Yadav; Gulam Moin Shaikh; Maushmi S Kumar; Meena Chintamaneni; Mayur Yc
Journal:  Front Chem       Date:  2022-06-13       Impact factor: 5.545

Review 2.  New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.

Authors:  Katerina Gurova
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

3.  9-Benzamido-acridinium chloride.

Authors:  Kun Huang; Kun-Ying Liu; Da-Bin Qin
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-03

4.  Targeted Tumor Therapy with Radiolabeled DNA Intercalator: A Possibility? Preclinical Investigations with 177Lu-Acridine.

Authors:  Subhajit Ghosh; Tapas Das; Shishu K Suman; Chandan Kumar; Haladhar D Sarma; Ashutosh Dash
Journal:  Biomed Res Int       Date:  2020-07-25       Impact factor: 3.411

5.  Novel therapeutic compound acridine-retrotuftsin action on biological forms of melanoma and neuroblastoma.

Authors:  Miroslawa Cichorek; Anna Ronowska; Monika Gensicka-Kowalewska; Milena Deptula; Iwona Pelikant-Malecka; Krystyna Dzierzbicka
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-26       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.